World News

For People with Cancer, Are Steroids the Best Treatment for Breathing...

Ogkologos - 25 Οκτωβρίου, 2022

Talazoparib Beyond BRCA Prospective Study Identifies the Sensitivity of gPALB2-Associated Breast...

Ogkologos - 25 Οκτωβρίου, 2022

Combination of Temozolomide and Capecitabine Associated with Improved PFS Compared to...

Ogkologos - 24 Οκτωβρίου, 2022

Do Birth Control Pills Impact My Cancer Risk?

Ogkologos - 20 Οκτωβρίου, 2022

Low-Pass Genomic Instability Characterisation Assay Identifies Germline Mismatch Repair Deficiency and...

Ogkologos - 20 Οκτωβρίου, 2022

EMA Recommends Granting a Marketing Authorisation for Lutetium (177Lu) Vipivotide Tetraxetan

Ogkologos - 19 Οκτωβρίου, 2022

How I Learned to Advocate for Myself During Cancer: “Your Stories”...

Ogkologos - 18 Οκτωβρίου, 2022

Long-Term Clinical Benefit with Nivolumab Plus Ipilimumab Extends Beyond Treatment Discontinuation...

Ogkologos - 18 Οκτωβρίου, 2022

Stopping the spread: A revolution in how we think about metastasis

Ogkologos - 18 Οκτωβρίου, 2022

Discover and translate – a mantra to work by

Ogkologos - 17 Οκτωβρίου, 2022

1...168169170...432 Σελίδα 169 από 432

MOST POPULAR

Little Girl Declared Cancer-Free For The Holidays Following 2 Years Of...

24 Δεκεμβρίου, 2021

Nivolumab plus Ipilimumab Improves PFS Over Chemotherapy Among Previously Untreated Patients...

9 Δεκεμβρίου, 2024

News digest – ovarian cancer blood test, statins, spending review and...

31 Οκτωβρίου, 2020

Datopotamab Deruxtecan Shows Promising Activity in Heavily Pretreated Advanced HR-positive/HER2-negative and...

7 Μαΐου, 2024

Φόρτωση περισσοτέρων

For People with Cancer, Are Steroids the Best Treatment for Breathing...

Talazoparib Beyond BRCA Prospective Study Identifies the Sensitivity of gPALB2-Associated Breast...

Combination of Temozolomide and Capecitabine Associated with Improved PFS Compared to...

Do Birth Control Pills Impact My Cancer Risk?

Low-Pass Genomic Instability Characterisation Assay Identifies Germline Mismatch Repair Deficiency and...

EMA Recommends Granting a Marketing Authorisation for Lutetium (177Lu) Vipivotide Tetraxetan

How I Learned to Advocate for Myself During Cancer: “Your Stories”...

Long-Term Clinical Benefit with Nivolumab Plus Ipilimumab Extends Beyond Treatment Discontinuation...

Stopping the spread: A revolution in how we think about metastasis

Discover and translate – a mantra to work by

MOST POPULAR

Little Girl Declared Cancer-Free For The Holidays Following 2 Years Of...

Nivolumab plus Ipilimumab Improves PFS Over Chemotherapy Among Previously Untreated Patients...

News digest – ovarian cancer blood test, statins, spending review and...

Datopotamab Deruxtecan Shows Promising Activity in Heavily Pretreated Advanced HR-positive/HER2-negative and...

HOT NEWS

Addressing the Barriers to Minority Participation in Cancer Clinical Trials

Percentage of Cancer Patients Who Are Eligible for and Respond to...

Man Gives Up His First-Class Seat For 88-Year-Old Woman, Makes Her...

Sacituzumab tirumotecan plus pembrolizumab significantly prolongs progression-free survival in advanced non-small...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ